Gsk Share Discussion Threads

[montyhedge] 27/1/2018 14:55

Dow flying Friday night, I think we may test 1400p next week,

[philanderer] 27/1/2018 00:25

More or less friday's Alphaville info...


"Dividend hopes help lift GlaxoSmithKline"

FT market report:

[red army] 26/1/2018 20:34

I can sympathise as I had it three years ago on my face and they told me my eye sight was at risk. Extremely painful.

[jrphoenixw2] 26/1/2018 19:23

Just in case it wasn't here but elsewhere I recounted my direct experience :)
I've had shingles. Got it aged 18 right after overlanding around India back in the 80s and coming home ravaged with amoebic dysentery [E. histolytica]. The shingles got me that young primarily because my immune system was so depleted it left me vulnerable.
The dysentery was dreadful, and recurred for months, cramps like you're having your guts ripped out. The shingles I had on my chest, and it came in waves too, and was like having my chest in a vice when it hit; genuinely agonising. On getting home from India I went straight to uni [reading parasitology /ironic] and there were several occasions I'd be in lectures and get a shingles hit, and just have tears of pain streaming down my face.
It is a dreadful thing, and thrives on the vulnerable. Perhaps I was lucky to get it young and not suffer any 2ndary neurological damage.
I'd recommend anyone eligible for a free vaccination to get it. Anyone younger who can afford it might consider it too. It's more widespread than is widely known, it's still quite a taboo thing to discuss having or having had.

[buywell3] 26/1/2018 17:34

Anyone like venison sausages ?

[montyhedge] 26/1/2018 14:20

ygor705
Any age can get it. GSK is the best vac, the other one is a live vac, GSK is not.

[montyhedge] 26/1/2018 14:13

Relative had Shingles lasted 8 weeks not nice, everyone should have a jab, just like a flu jab. Best £160 I spent.

[gbh2] 26/1/2018 13:56

Most certainly qualify age wise at 70, I suspect you'd need to be on some other "needs" list to qualify before.

[ygor705] 26/1/2018 13:47

Monty........you're obviously a young Turk, what the hell are you doing messing around with Shingles jabs? For the record, people in the UK in their late 60s, 70s and 80s qualify for free Shingles jabs at specific ages. Must be steady business for the NHS supplier with the number of people in these age brackets steadily increasing.

[montyhedge] 26/1/2018 13:13

That Shingles vac is a blockbuster, I paid £160 for a shingles vaccination, that was from a rival, before the GSK Vac appeared, GSK vac is suppose to be better.
Everyone over 50 should get vac, 1 in 3 will get Shingles sometime in their lives.

Yes 1 in 3

[gbh2] 26/1/2018 12:52

imo charting requires high volume interest which gsk doesn't have.

[tradermichael] 26/1/2018 12:45

More positive RNS:

Issued: 26 January 2018, London UK

GSK's Shingrix receives positive opinion from the CHMP in Europe for the prevention of shingles in adults aged 50 and over

[romeike] 26/1/2018 12:41

It goes on to say...

"If the company were to finance the Novartis put at £9.5bn and the Pfizer business at $16bn, we argue this could be done without a dividend cut – gearing would be uncomfortable in the very short term, but manageable."

Interesting they say £16bn, if Emma can get a ~25% discount perhaps it could turn out to be a good move that doesn't impact on the div.

[zho] 26/1/2018 11:57

"Such argument misses the point. The balance sheet can be flexed harder than is appreciated and our work argues a dividend cut is unlikely. Moreover, regardless of what is purchased or how it is funded, business development in consumer offers an epochal opportunity. It diversifies GSK beyond HIV, shores up cash flows to support pharma investment and positions the group for a potential split over the longer term. To focus solely on the dividend is to be in danger of overlooking the broader narrative."

........

"Cultural change at a company the size of GSK will take time to be reflected n the multiple, but, at the current valuation and with an appetising array of opportunities, the risk-reward is in its favour. In our best case scenario, the shares could trade towards 2000p by 2020. We upgrade our recommendation to Buy."

[darias] 26/1/2018 10:14

Yes but look out for the wipe out where most surfers invariably end.

[tradermichael] 26/1/2018 10:05

Charting is a little like surfing. You don't have to know a lot about the physics of tides, resonance, and fluid dynamics in order to catch a good wave. You just have to be able to sense when it's happening and then have the drive to act at the right time .... ;0)

[ttg100] 26/1/2018 09:55

chart starting to look a bit better
will wait a couple of days for confirmation then buy a few
GL all

[gbh2] 26/1/2018 09:50

I bought a few more on yesterdays drop.

[montyhedge] 26/1/2018 09:29

Good rns, should have a run back to 1365p.

[tradermichael] 26/1/2018 08:56

In (again) @ 1344.9 ... ;0)

[abdullla] 26/1/2018 08:11

Thanks, LOL!

[jrphoenixw2] 25/1/2018 21:58

LSE has lowest trade price today at 1330.40p, so, maybe take Abdulla with a large pinch of salt.

[abdullla] 25/1/2018 15:37

Sale is on at GSK!

[tradermichael] 25/1/2018 14:42

How did you get a price like that???